Jenscare Scientific Co., Ltd. (JENSCARE-B) has scheduled a board meeting for 31 August 2026, according to a company filing released on 19 August 2026 in Hong Kong.

The agenda will include: • Review and approval of the Group’s interim financial results for the six months ended 30 June 2026. • Authorization of the public release of the approved interim results. • Consideration of a recommendation for the payment of an interim dividend, if any. • Discussion of other routine corporate matters.

The meeting will be chaired by Executive Director and Chief Executive Officer Mr. Pan Fei. The Board currently comprises one executive director, five non-executive directors, and three independent non-executive directors.

No financial figures or dividend guidance were disclosed in the announcement; detailed performance metrics are expected upon publication of the interim results following the upcoming meeting.